Time limited offer for new users ▶ Get up to 3 months free

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
Boehringer Ingelheim
Dow
AstraZeneca
Johnson and Johnson

Last Updated: January 27, 2023

Patent: 5,011,678


✉ Email this page to a colleague

« Back to Dashboard

▶ Start for $1
Remove trial restrictions


Summary for Patent: 5,011,678
Title: Composition and method for administration of pharmaceutically active substances
Abstract:Pharmaceutically active substances are administered in aerosol form by applying to a mucosal surface of the body a composition comprising a medically effective amount of a pharmaceutically active substance, a biocompatible amphiphilac steroid and a bicompatible (hydro/fluoro)carbon propellant.
Inventor(s): Wang; Yu-chang J. (Los Altos, CA), Lee; William A. (Los Altos, CA), Narog; Blair (Palo Alto, CA)
Assignee: California Biotechnology Inc. (Mountain View, CA)
Application Number:07/305,520
Patent Claims:see list of patent claims

Details for Patent 5,011,678

Applicant Tradename Biologic Ingredient Dosage Form BLA Approval Date Patent No. Expiredate
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 10/28/1982 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 12/29/2015 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 08/06/1998 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-500 insulin human Injection 018780 03/31/1994 See Plans and Pricing 2039-02-26
Eli Lilly And Company HUMULIN R U-100 insulin human Injection 018780 05/25/2018 See Plans and Pricing 2039-02-26
Nps Pharmaceuticals, Inc. NATPARA parathyroid hormone For Injection 125511 01/23/2015 See Plans and Pricing 2039-02-26
Baxter Healthcare Corporation MYXREDLIN insulin human Injection 208157 06/20/2019 See Plans and Pricing 2039-02-26
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Approval Date >Patent No. >Expiredate

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Baxter
Boehringer Ingelheim
AstraZeneca
Harvard Business School
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.